Targeted therapy for HER2 positive breast cancer (Q26830496): Difference between revisions

From Wikidata
Jump to navigation Jump to search
Browse history interactively
← Older editNewer edit →
Fnielsen (talk | contribs)
1,126,926 edits
Fnielsen (talk | contribs)
1,126,926 edits
‎Undo revision 1117912524 by Fnielsen (talk): I am unsure whether this should be maintained
Tag: Undo
Property / main subject
 
Property / main subject: breast cancer / rank
 
Normal rank
Property / main subject: breast cancer / reference
 
stated in: PubMed Central
retrieved: 13 March 2019
Timestamp+2019-03-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / main subject: breast cancer / reference
 
stated in: PubMed
retrieved: 3 April 2019
Timestamp+2019-04-03T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / main subject: breast cancer / reference
 
stated in: PubMed
retrieved: 19 June 2019
Timestamp+2019-06-19T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / main subject: breast cancer / reference
 
stated in: PubMed
retrieved: 17 June 2019
Timestamp+2019-06-17T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 15:01, 18 February 2020

scientific article
Language Label Description Also known as
English
Targeted therapy for HER2 positive breast cancer
scientific article

    Statements

    instance of
    review article
    10 references
    stated in
    PubMed Central
    retrieved
    13 March 2019
    stated in
    PubMed
    retrieved
    3 April 2019
    stated in
    PubMed
    retrieved
    19 June 2019
    stated in
    PubMed
    retrieved
    17 June 2019
    stated in
    PubMed
    retrieved
    31 July 2019
    stated in
    PubMed
    retrieved
    2 August 2019
    stated in
    PubMed
    retrieved
    7 August 2019
    stated in
    PubMed
    retrieved
    28 September 2019
    stated in
    PubMed
    retrieved
    15 December 2019
    stated in
    PubMed
    retrieved
    18 December 2019
    title
    Targeted therapy for HER2 positive breast cancer (English)
    1 reference
    stated in
    PubMed
    main subject
    cell surface receptor
    1 reference
    stated in
    PubMed
    retrieved
    31 July 2019
    breast neoplasm
    6 references
    stated in
    PubMed
    retrieved
    31 July 2019
    stated in
    PubMed
    retrieved
    2 August 2019
    stated in
    PubMed
    retrieved
    7 August 2019
    stated in
    PubMed
    retrieved
    28 September 2019
    stated in
    PubMed
    retrieved
    15 December 2019
    stated in
    PubMed
    retrieved
    18 December 2019
    proto-oncogene protein
    1 reference
    stated in
    PubMed
    retrieved
    2 August 2019
    tumor biomarker
    1 reference
    stated in
    PubMed
    retrieved
    7 August 2019
    enzyme
    1 reference
    stated in
    PubMed
    retrieved
    28 September 2019
    membrane protein
    1 reference
    stated in
    PubMed
    retrieved
    15 December 2019
    neoplasm protein
    1 reference
    stated in
    PubMed
    retrieved
    18 December 2019
    breast cancer
    4 references
    stated in
    PubMed Central
    retrieved
    13 March 2019
    stated in
    PubMed
    retrieved
    3 April 2019
    stated in
    PubMed
    retrieved
    19 June 2019
    stated in
    PubMed
    retrieved
    17 June 2019
    author name string
    Jason A Incorvati
    series ordinal
    1
    1 reference
    stated in
    Crossref
    Shilpan Shah
    series ordinal
    2
    1 reference
    stated in
    Crossref
    Ying Mu
    series ordinal
    3
    1 reference
    stated in
    Crossref
    Janice Lu
    series ordinal
    4
    1 reference
    stated in
    Crossref
    volume
    6
    1 reference
    stated in
    PubMed
    page(s)
    38
    1 reference
    stated in
    PubMed
    cites work

    Identifiers

     
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q26830496&oldid=1117913024"